Exact Mass: 518.274
Exact Mass Matches: 518.274
Found 130 metabolites which its exact mass value is equals to given mass value 518.274
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Blumenol C O-[rhamnosyl-(1->6)-glucoside]
Blumenol C O-[rhamnosyl-(1->6)-glucoside] is found in fruits. Blumenol C O-[rhamnosyl-(1->6)-glucoside] is a constituent of quince (Cydonia vulgaris) leaves
triglyceride palmitate
PA(2:0/20:3(6,8,11)-OH(5))
PA(2:0/20:3(6,8,11)-OH(5)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/20:3(6,8,11)-OH(5)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 5-hydroxyeicosatetrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(20:3(6,8,11)-OH(5)/2:0)
PA(20:3(6,8,11)-OH(5)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(20:3(6,8,11)-OH(5)/2:0), in particular, consists of one chain of one 5-hydroxyeicosatetrienoyl at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
Ser Glu Lys Arg
Ser Glu Arg Lys
Thr Asp Lys Arg
Asp Glu Lys Lys
Asp Lys Glu Lys
Asp Lys Lys Glu
Asp Lys Arg Thr
Asp Lys Thr Arg
Asp Arg Lys Thr
Asp Arg Thr Lys
Asp Thr Lys Arg
Asp Thr Arg Lys
Glu Asp Lys Lys
Glu Lys Asp Lys
Glu Lys Lys Asp
Glu Lys Arg Ser
Glu Lys Ser Arg
Glu Arg Lys Ser
Glu Arg Ser Lys
Glu Ser Lys Arg
Glu Ser Arg Lys
Gly Met Arg Arg
Gly Arg Met Arg
Gly Arg Arg Met
Lys Asp Glu Lys
Lys Asp Lys Glu
Lys Asp Arg Thr
Lys Asp Thr Arg
Lys Glu Asp Lys
Lys Glu Lys Asp
Lys Glu Arg Ser
Lys Glu Ser Arg
Lys Lys Asp Glu
Lys Lys Glu Asp
Lys Arg Asp Thr
Lys Arg Glu Ser
Lys Arg Ser Glu
Lys Arg Thr Asp
Lys Ser Glu Arg
Lys Ser Arg Glu
Lys Thr Asp Arg
Lys Thr Arg Asp
Met Gly Arg Arg
Met Arg Gly Arg
Met Arg Arg Gly
Arg Asp Lys Thr
Arg Asp Thr Lys
Arg Glu Lys Ser
Arg Glu Ser Lys
Arg Gly Met Arg
Arg Gly Arg Met
Arg Lys Asp Thr
Arg Lys Glu Ser
Arg Lys Ser Glu
Arg Lys Thr Asp
Arg Met Gly Arg
Arg Met Arg Gly
Arg Arg Gly Met
Arg Arg Met Gly
Arg Ser Glu Lys
Arg Ser Lys Glu
Arg Thr Asp Lys
Arg Thr Lys Asp
Ser Lys Glu Arg
Ser Lys Arg Glu
Ser Arg Glu Lys
Ser Arg Lys Glu
Thr Asp Arg Lys
Thr Lys Asp Arg
Thr Lys Arg Asp
Thr Arg Asp Lys
Thr Arg Lys Asp
Blumenol C O-[rhamnosyl-(1->6)-glucoside]
Betamethasone butyrate propionate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
(2S)-2-[[(2S)-2-[[(2S,3S,6R,7R)-2-amino-8-(2-amino-1-carbamoyl-4,5-dihydroimidazol-4-yl)-3-azaniumyl-6,7,8-trihydroxyoctanoyl]amino]propanoyl]amino]-3-methylbutanoate
(2S)-2-[[(2S)-2-[[(2S,3S,6R,7R)-2,3-diamino-8-(2-amino-1-carbamoyl-4,5-dihydroimidazol-4-yl)-6,7,8-trihydroxyoctanoyl]amino]propanoyl]amino]-3-methylbutanoic acid
[(2R)-1-acetyloxy-3-phosphonooxypropan-2-yl] (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoate
[(2R)-2-acetyloxy-3-phosphonooxypropyl] (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoate
longirostrerone C
An azaphilone that is 9,9a-dihydro-6H-furo[2,3-h]isochromene-6,8(6aH)-dione substituted by a 6-methyl-2-oxocyclohex-3-en-1-yl group at position 3, a methyl group at position 6a and a 4,6,8-trimethyldeca-2,4-dienoyl group at position 9. Isolated from Chaetomium longirostre, it exhibits cytotoxic and antimalarial activities.
RF9 (hydrochloride)
RF9 hydrochloride is a potent and selective Neuropeptide FF receptor antagonist, with Ki values of 58 and 75 nM for hNPFF1R and hNPFF2R, respectively[1][2].